Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
about
Computational Approaches to Toll-Like Receptor 4 ModulationTLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial PathogensImmune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsSystemic injection of low-dose lipopolysaccharide fails to break down the blood-brain barrier or activate the TLR4-MyD88 pathway in neonatal rat brain.Danger signals - damaged-self recognition across the tree of life.Big opportunities for small molecules in immuno-oncology.Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms +896 and +1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk.Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties.Small-Molecule Carbohydrate-Based Immunostimulants.Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments.A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A.Integrated Approaches to Drug Discovery for Oxidative Stress-Related Retinal Diseases.Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.Is It Time to Reconsider the Lipopolysaccharide Paradigm in Acute Graft-Versus-Host Disease?Development of αGlcN(1↔1)αMan-based lipid A mimetics as a novel class of potent Toll-like receptor 4 agonists.Synthesis of anti-inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4).Characterization of complex, heterogeneous lipid A samples using HPLC-MS/MS technique I. Overall analysis with respect to acylation, phosphorylation and isobaric distribution.The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.Co-administration of Antimicrobial Peptides (AMPs) EnhancesToll-like Receptor 4 (TLR4) Antagonist Activity of a Synthetic Glycolipid.Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.Shikonin inhibits myeloid differentiation protein-2 to prevent lipopolysaccharide-induced acute lung injury.Aromatic-Turmerone Attenuates LPS-Induced Neuroinflammation and Consequent Memory Impairment by Targeting TLR4-Dependent Signaling Pathway.Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.A stereoselective thiocyanate conjugate addition to electron deficient alkynes and concomitant cyclization to N,S-heterocycles.Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists.Lipopolysaccharide Activates Toll-Like Receptor 4 and Prevents Cardiac Fibroblast-to-Myofibroblast Differentiation.Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.
P2860
Q26740008-4128ACFD-DED3-40E6-8397-5947514894EBQ26996513-6C6474E6-4E6E-463F-9E01-4A7218C56DC4Q28972540-73BBE3AE-E4C9-4CF6-A8C1-C25D8577C011Q33907683-9C934CA1-C0F5-4498-85AF-16E51E9ED3D3Q34433019-5BADC73B-419D-45D1-9640-8DB3C62DB178Q34487689-5B4F1A04-D716-4310-BD39-A07DF1B29EAEQ35687790-306A3DA6-00C0-43F5-8E0A-39614B0ED847Q35981265-C42B1966-106B-4F58-91D1-B378FB9DC06FQ36099284-0DB4E9C8-BC0A-4608-9513-F2FC9293EEB8Q38792526-D72BCA1C-028F-4F8E-87D3-215B4FA67B55Q38844616-458122CF-5C7F-4632-AF42-08FCB411C7F3Q38880983-D7AF5D0B-07F4-46B6-B75F-943A48D66B84Q38983228-A1BE4883-F378-4334-843E-D3E95E6FD4FAQ39039446-C29B37D5-5023-4F46-B407-2787D83CBC04Q39096977-C8674E99-883E-49A0-89C0-FED480DD6CB8Q41355730-473463F3-D8A1-45F3-8DB8-AD512367EC78Q41861865-663E6263-05A7-4FF8-BA48-B479ADB42074Q41882467-C9AE2DFF-74DE-4C34-A32F-4BB707AE9F0CQ46465656-A442AB17-F260-4E8B-8463-71052701AF7EQ47147061-3B3660A0-91E7-40D8-94ED-62D53CE9E6FAQ47266793-62DE24DE-23A2-47AC-A3CD-8A085201F265Q47270261-D1800641-A4E0-45B4-BB5C-173D3E1F68C5Q47291262-BAC53AD9-904A-405D-93D0-313C57B93D39Q47744530-5B764C78-1599-471A-BCAE-4F4003B4777DQ47769540-D94C5A4F-30DE-4757-AC07-8B0B713CC2CBQ48641496-09C6BBC8-581D-4C64-A86D-E5BF3C03ADB7Q49836090-6AEB45CA-A494-47E0-9CC4-BCEB6EDC1B7BQ50533018-25C2ABE1-D655-43EE-9C91-D3840652DFB3Q51129815-7FEBB715-7BFB-4F01-A4D4-ADF4F437E1B0Q55344710-4DD91C83-6B01-4E86-B469-41F99CE79F51
P2860
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@ast
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@en
type
label
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@ast
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@en
prefLabel
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@ast
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.
@en
P2860
P356
P1476
Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update
@en
P2093
Valentina Calabrese
P2860
P304
P356
10.1021/JM401006S
P407
P577
2013-11-20T00:00:00Z